Mobia Medical, Inc.: FDA filings under this applicant name
FDA lists 0 510(k) clearances under the applicant name “Mobia Medical, Inc.”, plus 1 PMA decision, across 1 product code in 1 review panel. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| QPY | Stimulator, Autonomic Nerve, Implanted For Stroke Rehabilitation | 1 | 0 |
Review panels
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P210007 | PMA | Vivistim® System | 2021-08-27 |
Recalls
openFDA lists no recalls under a recalling firm named Mobia Medical, Inc..
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
SEC filings
Mobia Medical, Inc. (MOBI): EDGAR filings, CIK 1489993. An SEC registrant with the same name, matched by name only.
Frequently asked questions
How many FDA 510(k) clearances are listed under Mobia Medical, Inc.?
FDA lists 0 510(k) clearances under the applicant name “Mobia Medical, Inc.”, plus 1 PMA decision, across 1 product code in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
Which FDA product codes appear under Mobia Medical, Inc.?
The most frequent FDA product codes under this applicant name are QPY (Stimulator, Autonomic Nerve, Implanted For Stroke Rehabilitation, 1).
Next steps
- See all 0 Mobia Medical, Inc. clearances with predicates and recalls
- Run predicate analysis for product code QPY, Mobia Medical, Inc.'s most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.